CD8 T Cell-Intrinsic GITR Is Required for T Cell Clonal Expansion and Mouse Survival following Severe Influenza Infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD8 T Cell-Intrinsic GITR Is Required for T Cell Clonal Expansion and Mouse Survival following Severe Influenza Infection

Published:2010-11-12 Issue:12 Volume:185 Page:7223-7234
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Snell Laura M.,McPherson Ann J.,Lin Gloria H. Y.,Sakaguchi Shimon,Pandolfi Pier Paolo,Riccardi Carlo,Watts Tania H.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. CD4+CD25+ Immunoregulatory T Cells

2. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance

3. GITR: A Modulator of Immune Response and Inflammation

4. Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques

5. Glucocorticoid-induced Tumor Necrosis Factor Receptor Negatively Regulates Activation of Human Primary Natural Killer (NK) Cells by Blocking Proliferative Signals and Increasing NK Cell Apoptosis

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targeting;American Journal of Cancer Research;2024

2. Prominent Targets for Cancer Care: Immunotherapy Perspective;Current Cancer Therapy Reviews;2023-11

3. GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy;iScience;2023-11

4. Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy;Cancers;2023-09-22

5. Targeting GITR in cancer immunotherapy - there is no perfect knowledge;Oncotarget;2023-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3